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Abstract
Background: Hepatocellular carcinoma is a common malignancy for which chronic hepatitis B
infection has been defined as the most common etiologic factor. The most frequent metastatic sites
are the lung, bone, lymphatics, and brain, respectively. Metastases to the chest wall have been
reported only rarely.
Case presentation: We report a patient with hepatocellular carcinoma who presented with an
isolated metastatic mass on the left anterolateral chest wall in the axillary region.
Conclusions: Metastasis of HCC should be included in the differential diagnosis of rapidly growing
lesions in unusual localizations, particularly in patients with chronic liver disease even if a primary
tumor can not be radiologically identified.
Background
Hepatocellular carcinoma (HCC) is the most frequent pri-
mary malignant tumor of the liver [1]. It is usually seen in
the 6th and 7th decades of life, and the most common eti-
ologic factor is chronic viral hepatitis, particularly in the
presence of cirrhosis. Chronic hepatitis B has been
described as the most frequent cause [2-4]. Hematogene-
ous extrahepatic metastases are common, with lungs,
regional lymph nodes, kidneys, bone marrow and
adrenals being the most frequent sites [3,4]. Rarely HCC
may present as a mass without a primary liver tumor
being identified [5-7].
This report presents an unusual metastasis of HCC which
presented as a mass on the left chest wall in the axillary
region.
Case presentation
A 71-year-old male was admitted to our clinic with com-
plaints of left shoulder pain, swelling in the left anterola-
teral chest wall, jaundice, weight loss, dyspnea and
weakness. At three months prior to admission, he had
noticed a less movable mass approximately 2 cm in diam-
eter and then the tumor had grown rapidly, becoming
increasingly painful during exertion. There was no history
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of expectoration, fever, or night sweats. The patient's
physical examination revealed yellow discoloration of the
sclerae, pitting edema up to the knees and a 5 cm × 6 cm
fixed mass in the left axillary region. There was mild
splenomegaly but no hepatomegaly, liver masses or
ascites. Laboratory findings were as follows: sedimenta-
tion rate: 90 mm/hr; Hb: 11.5 mg/dL; WBC: 3900/mm3;
Plt: 126 000/mm3; PT: 15.6 sec; INR:1.3; total protein: 6.5
g/dL (N: 6.4–8.5 g/dL); albumin: 2.2 g/dL (N: 3.4–4.8 g/
dL); AST: 124 iu/L (N: 15–40); ALT: 52 iu/L (N: 10–40);
ALP: 173 iu/L (N: 37–147); GGT: 213 iu/L (N:0–40); total
bilirubin: 3.8 mg/dL (N: 0.1–1.2), and direct bilirubin:
1.57 mg/dL (N: 0–0.3). Hepatitis B virus surface antigen,
IgG antibody to the core antigen, anti-HBe and HBV DNA
with polymerase chain reaction were positive. HBe anti-
gen, anti-Delta and serological markers of hepatitis C were
negative.
Abdominal ultrasonography showed ascites, splenomeg-
aly and diffusely nodular and heterogeneous echogenic
patterns in the liver. There was no history of chronic liver
disease. Upper gastrointestinal endoscopy was normal
except for esophageal varices. Computerized tomography
of the thorax revealed a mass on the left anterolateral
chest wall (Figure 1). Cytological examination of a fine
needle aspirate taken from the mass was consistent with
metastatic hepatocellular carcinoma (Figure 2). Abdomi-
nal computerized tomography detected thrombosis in the
right portal vein. The liver parenchyma was diffusely het-
erogeneous with irregular borders and without a clear
mass or infiltrating lesion. There was no lymphadenopa-
thy on thoracic, abdominal or pelvic computerized tom-
ography. The patient had an elevated serum alpha-feto
protein (AFP) level of 60 000 ng/mL (0 – 13.6 ng/ml).
Cytological examination of the liver confirmed the diag-
nosis of hepatocellular carcinoma. The patient was dis-
charged on palliative treatment, and he died 21 days later.
Discussion
Although extrahepatic metastasis of HCC was reported in
18% of untreated patients in a retrospective study, meta-
static lesions were found at a higher incidence in an
autopsy study of deaths related to primary liver cancer
[8,9]. The most common sites of extrahepatic involve-
ment are the lungs, lymph nodes, adrenal glands, and
bones [3,8,10-12]. Metastasis of HCC occurs frequently
by way of intrahepatic blood vessels, lymphatic permea-
tion, or direct infiltration. Hematogenous spread occurs
with the involvement of hepatic or portal veins or the
vena cava. Metastases have also been found in collaterals
and varices, and this appears to have been the route of
metastasis in the patient reported here. His right portal
vein was thrombosed, most likely due to tumoral infiltra-
tion. Tumor cells might have passed through the left tho-
racic wall via portosystemic collaterals, the azygous
system and finally intercostal veins. Another possible
route is through subcutaneous collaterals communicating
to thoracoepigastric veins and draining into the axillary
vein.
Thoracic computerized tomography showing a lesion of 7 cm  × 6.5 cm in diameter on the left anterolateral chest wall in  the left axillary region at the level of 4.–5. ribs with minimal  compressive atelectasis and destruction of the ribs Figure 1
Thoracic computerized tomography showing a lesion of 7 cm 
× 6.5 cm in diameter on the left anterolateral chest wall in 
the left axillary region at the level of 4.–5. ribs with minimal 
compressive atelectasis and destruction of the ribs.
The cell block section of the axillary mass is composed of  atypical hepatocytes forming thickened trabeculae and solid  nests lined by endothelial cells (H& E, ×100) Figure 2
The cell block section of the axillary mass is composed of 
atypical hepatocytes forming thickened trabeculae and solid 
nests lined by endothelial cells (H& E, ×100).BMC Cancer 2004, 4:89 http://www.biomedcentral.com/1471-2407/4/89
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Although bone metastases are seen in 10% of HCC
patients [13], it infrequently appears as the first manifes-
tation of HCC. The most common sites are the vertebra
and pelvis [14]. Isolated metastases of HCC to the ribs
have been rarely reported [5,6,15-17].
The establishment of the diagnosis of metastatic HCC can
occasionally be problematic, particularly when the pri-
mary tumor has not been identified. To the best of our
knowledge there are only two reports in the literature
describing cases of solitary metastasis to the chest wall
from an unknown primary HCC. One patient had an
HCC metastasis involving the sternum, and the other
patient had a metastasis on the right 4th rib [5,6].
In the present patient, the etiology of HCC was due to
chronic hepatitis B, and the HCC was diffuse in nature.
Yuki et al. reported an association between HBs antigen
positivity and diffuse-type HCC. Intrahepatic, hematoge-
nous and lymphogenous metastases have been frequently
observed in diffuse-type HCC [18]. Nevertheless, diffuse-
type HCC is often difficult to detect on imaging studies
because of its permeative appearance and heterogeneity of
background chronic liver disease [19]. In our patient,
although HCC was of the diffuse type, metastasis involve-
ment was isolated. There was also no regional lymph
node infiltration.
AFP, when elevated, usually correlates with tumor size.
AFP doubling time is also closely related to tumor dou-
bling time. A rapidly growing axillary mass, diffuse
tumoral infiltration of the liver and a very high level of
AFP in our patient are consistent with these observations.
However, nearly one-fourth of patients with HCC may
have normal AFP values [19].
The need for liver biopsy might be questionable in the our
patient. The presence of chronic liver disease with a very
high AFP level was highly suggestive for HCC. However,
there are several reports in the literature describing ectopic
HCC without a liver origin. These patients can be treated
with surgical resection and have a good prognosis [7,20].
Furthermore, several reports have claimed that ectopic liv-
ers are particularly predisposed to developing HCC [20-
22].
In conclusion, metastasis of HCC should be included in
the differential diagnosis of rapidly growing lesions in
unusual localizations, particularly in patients with
chronic liver disease even if a primary tumor cannot be
radiologically identified.
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